Harvey Partners, LLC Harvard Bioscience Inc Call Options Transaction History
Harvey Partners, LLC
- $1.07 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HBIO
# of Institutions
70Shares Held
20.1MCall Options Held
91.4KPut Options Held
11.5K-
Amh Equity LTD4.05MShares$2.63 Million2.46% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$1.85 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$1.2 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.07MShares$695,2980.0% of portfolio
-
Meros Investment Management, LP Dallas, TX918KShares$596,8680.18% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $27.1M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...